British drugmaker Indivior has agreed to buy Opiant, a US biotech specializing in treatments for addiction and drug overdose. Indivior will pay about $145 million upfront...
Plastic is everywhere: researchers have been able to detect it on Mount Everest as well as in the Mariana Trench. Particularly alarming was the recently published study...
Promoting comprehensive approaches in the industrial biotechnology sector for both current systems and future base chemicals; the dedicated Lohtragon BT range is under...
To meet surging global demand for its Jynneos-branded monkeypox vaccine, Danish biotech Bavarian Nordic (BN) is pulling out all stops. Strategies include outsourcing...
Lonza and Israel Biotech Fund (IBF) have signed a framework agreement, under which the Swiss CDMO will provide advice and support for Israeli biotech companies. IBF is...
Investment in UK biotech and life science companies scored a lifetime high in 2021, according to new data from the BioIndustry Association (BIA) and Clarivate.
China’s 14th Five-Year Plan “145” suggests that the dynamics initiated by the previous Five-Year Plan are to be maintained and even surpassed. As in the previous planning...
